Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Reversible cysteine protease inhibitors reported by Arris

Nov. 28, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996

Rx for Sjogren's syndrome symptoms nearing launch

Nov. 26, 1996

SKB to begin pivotal trials with antibody for RA

Nov. 22, 1996

Otsuka discloses inhibitor of TNF-alpha production

Nov. 21, 1996

Development of antiinflammatory/analgesic drug discontinued

Nov. 8, 1996

Progress on Scotia's rheumatoid arthritis treatment

Nov. 8, 1996

More convenient formulation of Lodine approved

Nov. 8, 1996

IL-1 receptor antagonists claimed by HMR/Affymax

Nov. 8, 1996

MMP inhibitors described by Procter & Gamble

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...